PCI The Journeys Within
Media Pack
News

Current Edition

JCS - Volume 18 Issue 3 - Autumn 2026
Frankfurt 2027 – 12/10/26
ramusmedical
news

REVVITY ESTABLISHES SCIENTIFIC CENTRE OF EXCELLENCE FOR GENOMIC INSIGHT IN CAMBRIDGE

Scientific Centre of Excellence aims to accelerate Revvity’s fundamental commitment of revolutionizing health science for a healthier humankind Focused on improv...
13 July 2023 news | Regional News
Continue Reading →
Regional News

Alkermes rebuffs challenge from activist investor Sarissa—for now

Shareholders in Alkermes have quelled a challenge from Sarissa Capital, reelecting seven board members and rejecting three nominees from the activist investor, the I...
6 July 2023 Regional News
Continue Reading →
Regional News

Novartis sells off dry eye disease med Xiidra, other ophthalmology assets to Bausch + Lomb for $2.5B

Novartis is passing off the dry eye disease drop Xiidra to eye health specialist Bausch + Lomb in a $2.5 billion deal, another step in the company's overhaul as it f...
6 July 2023 Regional News
Continue Reading →
Regional News

Fujifilm Diosynth taps company veteran Lars Petersen to drive CDMO toward $1.4B in annual revenue

Fujifilm has tapped a new leader on its quest to deliver 200 billion yen ($1.4 billion) from its Bio CDMO business by March 2025. Effective immediately, company v...
6 July 2023 Regional News
Continue Reading →
Regional News

Bristol Myers dominates list of the most seen ASCO display ads, muscling out Merck and Pfizer

Bristol Myers Squibb went big on display ads at this year's American Society of Clinical Oncology (ASCO) annual meeting. That is one of the takeaways of ZoomRx’s ana...
29 June 2023 Regional News
Continue Reading →
Regional News

Regeneron’s high-dose Eylea hit with surprise FDA rejection over manufacturing hiccups

Despite Regeneron’s impressive high-dose Eylea data, its high-stakes launch is delayed thanks to an unexpected FDA rejection.   The FDA turned down the closely wa...
29 June 2023 Regional News
Continue Reading →
Regional News

After Emergent’s rise and fall, CEO Robert Kramer announces retirement

Retiring from Emergent BioSolutions in 2010 didn’t take for Robert Kramer. He was wooed back to the company a year later and eventually became the contract manufactu...
29 June 2023 Regional News
Continue Reading →
Regional News

Lilly forks over $2.4M to settle federal agency’s age discrimination lawsuit

Eli Lilly is no stranger to age discrimination claims. But now, facing age bias allegations from employees and federal agencies alike, the Indianapolis-based drugmak...
29 June 2023 Regional News
Continue Reading →
Regional News

As Adderall shortages persist, Takeda’s rival Vyvanse is now in short supply

Many months into the U.S. shortage of attention-deficit/hyperactivity disorder (ADHD) drug Adderall and its generics, a rival medicine from Takeda is now in short su...
22 June 2023 Regional News
Continue Reading →
Regional News

Needle-free vaccine maker Vaxxas opens new manufacturing facility, HQ in Australia

Vaxxas, an Australian biotech developing needle-free vaccines, opened the doors to its new manufacturing digs in the country. The site will also serve as its gl...
22 June 2023 Regional News
Continue Reading →
Quotient
jcs-white.png

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Linkedin
Journal For Clinical Studies © 2026, All Rights Reserved – Powered by Teksyte